Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16390651rdf:typepubmed:Citationlld:pubmed
pubmed-article:16390651lifeskim:mentionsumls-concept:C0014098lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C0020887lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C1283828lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C1551357lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C0439836lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:16390651lifeskim:mentionsumls-concept:C0205157lld:lifeskim
pubmed-article:16390651pubmed:issue6lld:pubmed
pubmed-article:16390651pubmed:dateCreated2006-1-4lld:pubmed
pubmed-article:16390651pubmed:abstractTextThe purpose of this study was to compare the perioperative and long-term results of initial successful remote iliac artery endarterectomies (RIAEs) with converted procedures. From April 1994 to September 2003, 63 remote endarterectomies of the external and/or common iliac artery were planned in 62 patients (41 males, 42 procedures). The median age was 65 years (range 39-83 years), and the indication for operation was severe claudication in 37 (59%), rest pain in 16 (25%), and gangrene in 10 (16%) procedures. Initial technical success was achieved in 56 (89%) procedures (group 1); seven conversions (group 2) were necessary. In group 1, the 5-year primary patency rate improved from 64 +/- 15% to a primary assisted patency of 88 +/- 9.3% after percutaneous transluminal angioplasty in 11 patients, with 7 requiring stent placement. The 5-year secondary patency rate was 94 +/- 7.4%. The primary and secondary patency rates in group 2 were 86 +/- 19% and 100%, respectively. RIAE can be offered to patients with long occlusions of the iliac arteries as a first treatment option. The inherent risk of a possible conversion of an intended RIAE to a more invasive surgical procedure has no significant adverse clinical effect on the early and 5-year clinical outcomes.lld:pubmed
pubmed-article:16390651pubmed:languageenglld:pubmed
pubmed-article:16390651pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16390651pubmed:citationSubsetIMlld:pubmed
pubmed-article:16390651pubmed:statusMEDLINElld:pubmed
pubmed-article:16390651pubmed:issn1708-5381lld:pubmed
pubmed-article:16390651pubmed:authorpubmed-author:SmeetsLuukLlld:pubmed
pubmed-article:16390651pubmed:authorpubmed-author:GisbertzSuzan...lld:pubmed
pubmed-article:16390651pubmed:authorpubmed-author:MollFransFlld:pubmed
pubmed-article:16390651pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:16390651pubmed:authorpubmed-author:HoGwanGlld:pubmed
pubmed-article:16390651pubmed:issnTypePrintlld:pubmed
pubmed-article:16390651pubmed:volume13lld:pubmed
pubmed-article:16390651pubmed:ownerNLMlld:pubmed
pubmed-article:16390651pubmed:authorsCompleteYlld:pubmed
pubmed-article:16390651pubmed:pagination336-42lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:meshHeadingpubmed-meshheading:16390651...lld:pubmed
pubmed-article:16390651pubmed:articleTitleDoes conversion of intended remote iliac artery endarterectomy alter the early and long-term outcome?lld:pubmed
pubmed-article:16390651pubmed:affiliationDepartment of Surgery, Twenteborg Hospital, Almelo, the Netherlands. smeets_luuk@hotmail.comlld:pubmed
pubmed-article:16390651pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16390651pubmed:publicationTypeEvaluation Studieslld:pubmed